MIchael J Fox Foundation – PPMI Biofluid Biomarkers Program
Ends on 27 May 2025
This Parkinson’s Progression Markers Initiative (PPMI) program seeks to identify collaborators who have analytically validated biomarker assays to deploy in existing PPMI biosamples to enhance the biological definition of Parkinson’s disease (PD) and related disorders, both before and after symptom onset.